Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,734 GBX | +0.29% | +3.80% | +19.54% |
05-06 | GSK : UBS remains its Buy rating | ZD |
05-03 | GSK : DZ Bank remains Neutral | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.54% | 88.72B | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline Says FDA Accepted its New Drug Application for Momelotinib to Treat Myelofibrosis Patients With Anemia